NDVR »

Regeneron Pharmaceuticals shares owned by NDVR

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by NDVR from 13F filings

Historical chart of NDVR investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by NDVR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by NDVR

Quarter filed Position value Share count Share price at filing
2024-03-31 $210k 218 962.49

More positions owned by NDVR

Hubspot (HUBS)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
World Gold Tr Spdr Gld Minis (GLDM)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Epam Systems (EPAM)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Meta Platforms Cl A (META)
Exxon Mobil Corporation (XOM)

View all positions for NDVR

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals